Emmanuelle Vallez

2.1k total citations
29 papers, 1000 citations indexed

About

Emmanuelle Vallez is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Emmanuelle Vallez has authored 29 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Emmanuelle Vallez's work include Liver Disease Diagnosis and Treatment (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and Peroxisome Proliferator-Activated Receptors (8 papers). Emmanuelle Vallez is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and Peroxisome Proliferator-Activated Receptors (8 papers). Emmanuelle Vallez collaborates with scholars based in France, Belgium and United States. Emmanuelle Vallez's co-authors include Bart Staels, Anne Tailleux, Sophie Lestavel, Sandrine Caron, Fanny Lalloyer, Philippe Lefèbvre, Jonathan Vanhoutte, Nathalie Hennuyer, Kadiombo Bantubungi and Véronique Touche and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and Diabetes.

In The Last Decade

Emmanuelle Vallez

27 papers receiving 987 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuelle Vallez France 17 415 308 295 259 252 29 1000
Hitomi Usui Japan 13 444 1.1× 297 1.0× 249 0.8× 189 0.7× 369 1.5× 14 1.6k
Hitoshi Minakuchi Japan 15 525 1.3× 313 1.0× 232 0.8× 324 1.3× 246 1.0× 29 1.4k
Miyuki Yano Japan 12 772 1.9× 237 0.8× 279 0.9× 266 1.0× 151 0.6× 12 1.3k
Joshua E. Basford United States 19 479 1.2× 344 1.1× 260 0.9× 314 1.2× 171 0.7× 22 1.2k
Fanny Lalloyer France 12 558 1.3× 248 0.8× 248 0.8× 194 0.7× 163 0.6× 17 909
Jane Honeyman Australia 13 758 1.8× 456 1.5× 370 1.3× 450 1.7× 221 0.9× 14 1.3k
Iryna Voloshyna United States 16 349 0.8× 134 0.4× 306 1.0× 123 0.5× 90 0.4× 34 1.1k
Ryan D. Sheldon United States 20 522 1.3× 298 1.0× 126 0.4× 310 1.2× 120 0.5× 59 1.2k
Kun Zhou China 13 419 1.0× 292 0.9× 152 0.5× 233 0.9× 131 0.5× 47 1.1k
Keiichiro Matoba Japan 18 480 1.2× 154 0.5× 166 0.6× 129 0.5× 337 1.3× 41 1.2k

Countries citing papers authored by Emmanuelle Vallez

Since Specialization
Citations

This map shows the geographic impact of Emmanuelle Vallez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Vallez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Vallez more than expected).

Fields of papers citing papers by Emmanuelle Vallez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuelle Vallez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Vallez. The network helps show where Emmanuelle Vallez may publish in the future.

Co-authorship network of co-authors of Emmanuelle Vallez

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuelle Vallez. A scholar is included among the top collaborators of Emmanuelle Vallez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuelle Vallez. Emmanuelle Vallez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henry, Doriane, Eric Baugé, Nathalie Hennuyer, et al.. (2025). Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr- deficient mice. Science Translational Medicine. 17(800). eadj8192–eadj8192.
2.
Ouk, Thavarak, Maud Pétrault, Emmanuelle Vallez, et al.. (2024). Endothelial Dysfunction and Pre-Existing Cognitive Disorders in Stroke Patients. Biomolecules. 14(6). 721–721.
3.
Hennuyer, Nathalie, Isabelle Duplan, Emmanuelle Vallez, et al.. (2024). Insulin‐degrading enzyme inhibition increases the unfolded protein response and favours lipid accumulation in the liver. British Journal of Pharmacology. 181(19). 3610–3626. 6 indexed citations
4.
Dehondt, Hélène, Arianna Marino, Laura Butruille, et al.. (2023). Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis. Molecular Metabolism. 69. 101686–101686. 16 indexed citations
5.
Aboulouard, Soulaimane, Émilie Faivre, Kévin Carvalho, et al.. (2023). Multi-Omics Data Integration Reveals Sex-Dependent Hippocampal Programming by Maternal High-Fat Diet during Lactation in Adult Mouse Offspring. Nutrients. 15(21). 4691–4691. 2 indexed citations
6.
Domenger, Dorothée, Sarah Ducastel, Emilie Dorchies, et al.. (2022). Farnesoid X Receptor Activation in Brain Alters Brown Adipose Tissue Function via the Sympathetic System. Frontiers in Molecular Neuroscience. 14. 808603–808603. 14 indexed citations
7.
L’homme, Laurent, Olivier Molendi‐Coste, Sébastien Fleury, et al.. (2020). Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH. Scientific Reports. 10(1). 21095–21095. 6 indexed citations
8.
Ducastel, Sarah, Véronique Touche, Mohamed Trabelsi, et al.. (2020). The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids. Scientific Reports. 10(1). 174–174. 57 indexed citations
9.
Leboucher, Antoine, Tariq Ahmed, Émilie Caron, et al.. (2019). Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model. Neurobiology of Disease. 125. 14–22. 18 indexed citations
10.
Chávez‐Talavera, Oscar, Matthieu Wargny, Matthieu Pichelin, et al.. (2019). Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes. Metabolism. 103. 154042–154042. 33 indexed citations
11.
Chávez‐Talavera, Oscar, Grégory Baud, Valeria Spinelli, et al.. (2017). Roux-en-Y gastric bypass increases systemic but not portal bile acid concentrations by decreasing hepatic bile acid uptake in minipigs. International Journal of Obesity. 41(4). 664–668. 19 indexed citations
12.
Wouters, Kristiaan, Yann Deleye, Sarah Anissa Hannou, et al.. (2017). The tumour suppressor CDKN2A/p16INK4a regulates adipogenesis and bone marrow-dependent development of perivascular adipose tissue. Diabetes and Vascular Disease Research. 14(6). 516–524. 14 indexed citations
13.
Legry, Vanessa, Sven Francque, Joel T. Haas, et al.. (2017). Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects. The Journal of Clinical Endocrinology & Metabolism. 102(10). 3783–3794. 79 indexed citations
14.
Hennuyer, Nathalie, Isabelle Duplan, Charlotte Paquet, et al.. (2016). The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis. Atherosclerosis. 249. 200–208. 110 indexed citations
15.
Spinelli, Valeria, Fanny Lalloyer, Grégory Baud, et al.. (2016). Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans. International Journal of Obesity. 40(8). 1260–1267. 63 indexed citations
16.
Spinelli, Valeria, Céline Martin, Emilie Dorchies, et al.. (2015). Screening strategy to generate cell specific recombination: a case report with the RIP-Cre mice. Transgenic Research. 24(5). 803–812. 7 indexed citations
17.
Leboucher, Antoine, Cyril Laurent, Francisco-José Fernández-Gómez, et al.. (2012). Detrimental Effects of Diet-Induced Obesity on τ Pathology Are Independent of Insulin Resistance in τ Transgenic Mice. Diabetes. 62(5). 1681–1688. 80 indexed citations
18.
Baron, Morgane, Aurélie S. Leroyer, Zouher Majd, et al.. (2011). PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH. Atherosclerosis. 218(1). 69–76. 20 indexed citations
19.
Lalloyer, Fanny, Kristiaan Wouters, Morgane Baron, et al.. (2011). Peroxisome Proliferator–Activated Receptor-α Gene Level Differently Affects Lipid Metabolism and Inflammation in Apolipoprotein E2 Knock-In Mice. Arteriosclerosis Thrombosis and Vascular Biology. 31(7). 1573–1579. 60 indexed citations
20.
Caron, Sandrine, An Verrijken, Ilse Mertens, et al.. (2010). Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia. Arteriosclerosis Thrombosis and Vascular Biology. 31(3). 513–519. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026